J&J Shares Slump 6% Despite Earnings Beat and Upgraded 2026 Guidance

Key Facts

1Johnson & Johnson reported earnings that exceeded expectations and raised its financial guidance for 2026.

2The company's stock fell nearly 6% in a single session despite the positive results.

Johnson & Johnson reported earnings that exceeded expectations and raised its financial guidance for 2026, according to 247wallst.com. Despite the positive headline figures, the company's stock fell nearly 6% in a single session as investors reacted to the underlying details of the fiscal report.

JNJ closed at $248.61 on October 13, 2026, with the session seeing a high of $256.18 and a low of $245.17. The sharp decline occurred despite the upgraded outlook, with analyst facts suggesting the sell-off may be linked to concerns over settlement charges or a "sell the news" reaction following previous guidance updates.